Today GENALICE and Knome, Inc. USA jointly announced that the Swiss Foundation for People with Rare Diseases has chosen to use their solutions in tandem to improve the Foundation’s processing and analysis of their Next-Generation Sequencing (NGS) data.
via Technology - Latest News http://ift.tt/1oA8QPa
via Technology - Latest News http://ift.tt/1oA8QPa
No comments:
Post a Comment